Key aspects of soft tissue management in fracture-related infection: recommendations from an international expert group.

Arch Orthop Trauma Surg · Jan 2024 · Review

Marais LC, Hungerer S, Eckardt H, Zalavras C, Obremskey WT, Ramsden A, et al.

Department of Trauma Surgery, University Hospitals Leuven, Leuven, Belgium

Orthopaedic Trauma

SUMMARY — THE REDUCTIONSoft tissue management in fracture-related infection requires meticulous debridement, consideration of closure timing and negative cultures, appropriate flap selection, and potential negative pressure therapy.
Abstract, as published

A judicious, well-planned bone and soft tissue debridement remains one of the cornerstones of state-of-the-art treatment of fracture-related infection (FRI). Meticulous surgical excision of all non-viable tissue can, however, lead to the creation of large soft tissue defects. The management of these defects is complex and numerous factors need to be considered when selecting the most appropriate approach. This narrative review summarizes the current evidence with respect to soft tissue management in patients diagnosed with FRI. Specifically we discuss the optimal timing for tissue closure following debridement in cases of FRI, the need for negative microbiological culture results from the surgical site as a prerequisite for definitive wound closure, the optimal type of flap in case of large soft tissue defects caused by FRI and the role of negative pressure wound therapy (NPWT) in FRI. Finally, recommendations are made with regard to soft tissue management in FRI that should be useful for clinicians in daily clinical practice.Level of evidence Level V.

Featured in the 2026-07-20 issue.

← Musculoskeletal Effects of Cancer and Cancer Treatment.Venous thromboembolism in children with lower limb fractures:… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.